Nevada PDMP Update: Schedule 5 (CV) Medications will be reported to the NV PDMP starting June 15, 2022. Providers dispensing CV in Nevada will need to have a DEA number added to their provider profile and inventory will need to have Manufacturer (Reference) NDCs.
Nevada PMDP Update: Schedule 5 drugs to begin reporting on June 15, 2022
Beginning June 15th, MDScripts will begin reporting Schedule 5 (CV) medications to the Nevada PDMP system. This will require any provider dispensing CV medications to have a DEA license added to their profile as well as Reference NDCs for medication inventory. Other patient required fields may also need to be entered as needed to meet state reporting requirements.